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Atropine-resistant bradycardia due to
hyperkalaemia
T J Slade,1 J Grover,2 J Benger1
Symptomatic sinus bradycardia is routinely treated in the emergency department with atropine and
pacing. Two cases are presented that illustrate the importance of considering hyperkalaemia,
particularly in the presence of atropine-resistant symptomatic bradycardia. The administration of
calcium in such cases acts to stabilise the myocardium and resolve the bradycardia. Blood gas
analysis provides a rapid estimate of serum potassium concentrations, facilitating timely treatment.
CASE 1
A 68-year-old man was brought to the
emergency department (ED) having col-
lapsed after dinner. The ambulance crew
recorded an initial pulse rate of 33 and
blood pressure of 80/30 mm Hg. He
received 1.5 mg atropine pre-hospital with
no discernable effect. His past medical
history included hepatic failure and myo-
cardial infarction and current medications
were metoprolol, valsartan, spironolactone
(dose recently increased), clopidogrel,
aspirin, atorvastatin and omeprazole.
On arrival in the ED he was conscious,
with a heart rate varying between 38 and
45. His arrival ECG revealed a sinus
rhythm with an increased PR interval
(210 ms), broadened QRS complexes and
a QTc of 444 ms (fig 1). A venous blood
gas gave a potassium result of 8.1 mmol/l,
with hyperkalaemia confirmed by a sub-
sequent laboratory report of 8.4 mmol/l.
A further 1 mg intravenous atropine
was given without effect. However, 5 mg
nebulised salbutamol and 2 g intravenous
calcium chloride administered over
5 minutes caused the heart rate to
increase to 68 with a blood pressure of
128/80 mm Hg. The patient was subse-
quently admitted to hospital and was
discharged well following review of his
regular medications.
CASE 2
An 84-year-old man was brought to the ED
by ambulance. He had been feeling gen-
erally unwell for 24 h. When the ambu-
lance arrived the patient collapsed, with an
initial heart rate of 40, falling to 20 and
with a blood pressure of 70/55 mm Hg.
Atropine 2.5 mg and 500 ml 0.9% saline
were administered with no response. He
had type 2 diabetes with a history of
hypertension. Medications were aspirin,
rosiglitazone, lisinopril, digoxin, gliclazide,
bendroflumethiazide and diltiazem.
On arrival in the ED his pulse rate
remained 20, but with a blood pressure of
103/79 mm Hg. The ECG revealed a
bizarre wide complex rhythm with no
identifiable P waves (fig 2).
An arterial blood gas revealed a pH of
7.16 and potassium of 8.02 mmol/l, with
hyperkalaemia confirmed by a subsequent
laboratory report of 8.3 mmol/l. Calcium
chloride 2 g was administered intrave-
nously over 5 minutes, with immediate
resolution of the bradycardia and the
patient became fully alert. The heart rate
improved to 84 with a blood pressure of
110/84 mm Hg. Further treatment for
hyperkalaemia was administered and the
patient subsequently made a full recovery.
Figure 1 Case 1: Initial electrocardiogram showing sinus bradycardia.
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DISCUSSION
The classic ECG signs of hyperkalaemia
include:1
c Narrow-based peaked T waves (serum
potassium .5.5 mmol/l)
c Prolonged QRS and PR interval and
flattened P waves (.6.5 mmol/l)
c Intraventricular blocks, bundle branch
blocks (.8.0 mmol/l)
c Eventual ‘‘sine-wave’’ QRS complexes,
ventricular fibrillation, asystole
Many other ECG abnormalities have,
however, been attributed to hyperkalaemia.
These include both tachycardia and brady-
cardia and also idioventricular rhythm,
heart block and a pseudo-infarction pattern
with massive ST segment elevation.1 2
Life-threatening hyperkalaemia causing
profound bradycardia can appear to
resemble complete heart block (as in case
2); however, there is an absence of P
waves. A UK case report has previously
highlighted the resolution of hyperkalae-
mic bradycardia with intravenous calcium
administration.3 This phenomenon is not
described in the emergency medicine
literature, however, and appears to be
poorly recognised as a cause of sympto-
matic bradycardia.
The effects of calcium occur within 1–
3 minutes but last for only 30–60 minutes2
and definitive treatment is needed to lower
serum potassium levels. When arrhythmias
are present, a wealth of anecdotal and
animal data suggest that intravenous cal-
cium is effective in treating arrhythmia.
Further studies of the optimal use of
combination treatments and of the adverse
effects of treatments are needed.4
The patient in case 2 took digoxin
regularly. Because hypercalcaemia can
potentiate digitalis toxicity, calcium should
be used in patients taking digitalis only if
there is a loss of P waves or a widened QRS
complex. In this situation, calcium gluco-
nate should be diluted in 100 ml 5%
dextrose and infused over 30 minutes.2
Bradycardia secondary to hyperkalae-
mia is not a commonly recognised ECG
finding. These cases show the value of
both rapid bedside testing of serum
potassium in the ED (by arterial blood
gas analyser) and clinicians having an
awareness of the many and varied ECG
presentations of hyperkalaemia.
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Figure 2 Case 2: Initial electrocardiogram showing wide QRS complexes without discernable P
waves.
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